🇺🇸 FDA
Patent

US 10456390

Combinations comprising MABA compounds and corticosteroids

granted A61KA61K31/4709A61K31/56

Quick answer

US patent 10456390 (Combinations comprising MABA compounds and corticosteroids) held by Almirall, S.A. expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4709, A61K31/56, A61K31/573, A61K31/575